Results 181 to 190 of about 15,332 (256)
A physics primer on photon‐counting detectors in CT: Physics, signal formation, and performance
Abstract Photon‐counting detector CT (PCD‐CT) is moving from laboratory development to clinical deployment. However, its threshold‐bin data arise from a tightly coupled detector–readout chain that can be difficult to understand as a whole. These data are not a direct readout of photon energy, but the outcome of a sequence of physical and electronic ...
Guang‐Hong Chen, Ruiran Lai, Ke Li
wiley +1 more source
Characterizing industry payments for FDA-approved AI medical devices. [PDF]
Bergman A, Patel TA, Shah KP.
europepmc +1 more source
Abstract Objective Artificial intelligence (AI) has advanced to simultaneously process visual, auditory, and textual inputs, providing users with “multimodal” AI. Given the clinical integration potential of these tools, otolaryngologists must stay informed. This study reviews current literature on applications of multimodal AI in otolaryngology.
Ying Jie Li +5 more
wiley +1 more source
Artificial Intelligence in Exams by Image: Ethical Pros and Cons. [PDF]
Zachini C, Nunes S, Rego F, Nunes R.
europepmc +1 more source
How to bring generative AI to oncology practice. [PDF]
Truhn D, Kather JN.
europepmc +1 more source
Occupational exposure to metal welding and cataract: A systematic review and meta‐analysis
Abstract Background Metal welding generates ultraviolet radiation (UVR) of cataractogenic wavelengths, and UVR emitted during welding has been associated with cataract formation, but results from prior studies are conflicting. Methods We conducted a systematic review and meta‐analysis of epidemiological studies addressing associations between ...
Jakob Bjerager +5 more
wiley +1 more source
Clinical Safety of Gadoxetate Disodium: Insights From 20 Years of Use and More Than 12 Million Administrations. [PDF]
Endrikat J +5 more
europepmc +1 more source
This review presents a systems‐oriented roadmap for integrating artificial intelligence into medicinal plant drug discovery to overcome persistent bottlenecks like extract complexity. It highlights that advancing toward reproducible therapeutics requires making phytochemical datasets AI‐ready via rigorous harmonization and phyto‐centric foundational ...
Amit Gangwal +5 more
wiley +1 more source
Scoping review of regulatory transparency in AI-based radiology software: analysis of PMDA-approved SaMD products. [PDF]
Kikuchi T +10 more
europepmc +1 more source
ABSTRACT Background The recent approval of disease‐modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. Biomarker confirmation of amyloid pathology is now required alongside clinical assessment, and blood‐based tests are improving accessibility.
Tim Van Langenhove +31 more
wiley +1 more source

